
Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but …
The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

